PUBLISHED FOR OPPOSITION
on 12 Nov 2024
Last Applicant/ Owned by
5345 Indian Lookout Road
Cazenovia
NY
13035
Serial Number
98199404 filed on 27th Sep 2023
Registration Number
N/A
Correspondent Address
Jeffrey M. Mustari
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION
Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; Testing, analysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; Testing, analysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards
First Use Date in General
09th Feb 2022
First Use Date in Commerce
09th Feb 2022
Mark Details
Serial Number
No 98199404
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.01.03 -
A single star with five points
27.03.05 -
Representations of objects forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 23rd Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 22nd Aug 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 22nd Aug 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 22nd Aug 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 23rd May 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 23rd May 2024 | NON-FINAL ACTION WRITTEN |
| 23rd May 2024 | NON-FINAL ACTION E-MAILED |